Heart Rhythm Medication Management
What is it?
Some cardiac arrhythmias may be treated through medication management. This option should be discussed with a cardiologist, who will choose a drug based on the type of arrhythmia and any other underlying heart disease or risk factors present. There are several classes of medications commonly used:
Beta blockers decrease heart rate and cardiac output to block the effects of adrenaline on the heart. This can in turn lower blood pressure.
Anti-arrhythmic medications may be used to prevent arrhythmias from happening or to convert an abnormal rhythm back to a normal rhythm. In emergency situations, anti-arrhythmics can be given through an intravenous (IV) line. They also may be given for daily, long-term treatment of fast heartbeats (tachycardias) and premature beats.
Calcium channel blockers help treat arrhythmias by keeping calcium from moving into the heart and blood vessel tissue.
Anticoagulants keep blood from clotting, which can help prevent strokes. People with atrial fibrillation are more susceptible to blood clot formation.
All treatments, including medication management, carry risks and benefits. To best treat your condition, patients should be sure come prepared with a list of all medications and supplements. This can help as we tailor the best treatment plan for treating cardiac arrhythmias and other underlying conditions.
The Loyola difference
Loyola serves as a major regional and national referral center for the treatment of atrial fibrillation, offering treatment options often unavailable elsewhere. Our skilled team of leading electrophysiologists, advanced practice nurses, technical staff, imaging experts and other professionals provides an integrated approach to the diagnosis and treatment of a variety of rhythm disturbances and their associated underlying conditions.
Loyola is a nationally recognized leader in cardiac care. U.S. News & World Report ranked us 18th in the nation for cardiology and heart surgery in 2012, making this our 10th year in the top 50.
Learn more about our performance outcomes.